You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostate Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

From Lung and Blood Samples in Suspected Lung Cancer

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Bronchoscopic Biopsy
  • Blood Sample
  • Farmington, Connecticut
  • +4 more
Aug 17, 2022

Potential Clinical Utilities of Circulating Tumor DNA in

Not yet recruiting
  • Gastric Cancer
  • Circulating Tumor DNA (ctDNA)
    • (no location specified)
    Aug 21, 2022

    Endometrial Serous Adenocarcinoma Trial in United States (Biospecimen Collection, Resection, Triapine)

    Recruiting
    • Endometrial Serous Adenocarcinoma
    • Biospecimen Collection
    • +2 more
    • Coral Gables, Florida
    • +5 more
    Aug 23, 2022

    NSCLC Trial in Chendu (Almonertinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • Chendu, Sichuan, China
      West China Hospital，Sichuan University
    Dec 14, 2022

    Long Term Survivors of Ovarian Cancer

    Active, not recruiting
    • Ovarian Cancer
    • Questionnaire
    • Interview
    • West Hollywood, California
    • +4 more
    Aug 22, 2022

    Developing a MRI-based Deep Learning Model to Predict MMR Status

    Not yet recruiting
    • Endometrial Cancer
    • randomly divided
    • (no location specified)
    Mar 13, 2023

    Lyme Borreliosis Trial in United States (VLA15, Placebo)

    Active, not recruiting
    Has Results
    • Lyme Borreliosis
    • VLA15
    • Placebo
    • Milford, Connecticut
    • +4 more
    Jul 6, 2021

    Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8 Trial in Duarte (Copper Cu

    Recruiting
    • Locally Advanced Rectal Carcinoma
    • +4 more
    • Copper Cu 64 Anti-CEA Monoclonal Antibody M5A
    • Imaging Technique
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    Colon Cancer Trial in Daegu (timing to initiate the adjuvant chemo)

    Active, not recruiting
    • Colon Cancer
    • timing to initiate the adjuvant chemotherapy
    • Daegu, Korea, Republic of
    • +1 more
    Dec 21, 2022

    Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin

    Active, not recruiting
    • Breast Carcinoma
    • +4 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 28, 2022

    Esophageal Trial in Nanjing ("Endostar", Liposo, cisplatin)

    Terminated
    • Esophageal
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jul 28, 2022

    Intraoperative Flow Cytometry In Colorectal Cancer

    Completed
    • Colorectal Cancer
    • flow cytometry
    • Ioannina, Epirus, Greece
      University Hospital of Ioannina
    Feb 18, 2022

    Remote Breast Cancer Screening Study

    Recruiting
    • Breast Cancer
    • +4 more
    • Conventional-reading
    • +4 more
    • Xi'an, Shaanxi, China
    • +1 more
    Aug 14, 2022

    Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

    Active, not recruiting
    • Stomach Neoplasms
    • +2 more
    • Beijing, China
    • +10 more
    Dec 21, 2022

    NSCLC Trial in Santa Rosa, Ridgewood (Tipifarnib, Osimertinib)

    Recruiting
    • NSCLC
    • Santa Rosa, California
    • +1 more
    Jan 11, 2023

    Urinary Bladder Tumors Trial in Worldwide (Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy

    Recruiting
    • Urinary Bladder Neoplasms
    • Washington, District of Columbia
    • +120 more
    Jan 19, 2023

    Breast Cancer, Brain Metastases Trial in United States (Whole Brain Radiotherapy (WBRT), Sorafenib)

    Completed
    • Breast Cancer
    • Brain Metastases
    • Basking Ridge, New Jersey
    • +5 more
    Mar 4, 2022

    First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

    Not yet recruiting
    • First-line Treatment of Non-clear Renal Cell Carcinoma
    • Fruquintinib combined with Serplulimab
    • (no location specified)
    Apr 16, 2023

    Stage IV NSCLC, Targeted Therapy, Nonsmall Cell Lung Cancer Trial in Boston (POISE)

    Not yet recruiting
    • Stage IV Non-small Cell Lung Cancer
    • +7 more
    • POISE
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 13, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Ovarian Cancer Trial in Lexington (Artemisia annua 450mg, Artemisia annua 900mg, Artemisia annua 1350mg)

    Recruiting
    • Ovarian Cancer
    • Artemisia annua 450mg
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Jan 4, 2023

    Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

    Not yet recruiting
    • Pancreatic Cancer, Stage IB
    • +3 more
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Jan 4, 2023

    Gallbladder Adenocarcinoma Trial in Morgantown (HIPEC)

    Not yet recruiting
    • Gallbladder Adenocarcinoma
    • Morgantown, West Virginia
      West Virginia University Cancer Institute Mary Babb Randolph Can
    Jun 23, 2022

    ER+ HER2- Advanced Breast Cancer Trial in Spain, United Kingdom, United States (AZD9833, AZD9833 with palbociclib, AZD9833 with

    Recruiting
    • ER+ HER2- Advanced Breast Cancer
    • Aurora, Colorado
    • +16 more
    Aug 22, 2022